ENTITY
Johnson & Johnson

Johnson & Johnson (JNJ US)

251
Analysis
Health Care • United States
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
more
bullish•BNP Paribas
•31 Jan 2020 17:25

They're Here: ESG Short Sellers

ESG short selling – i.e., shorting based on ESG metrics and catalysts – isn't new, but is undergoing a radical evolution. Short-term ESG trading...

Logo
653 Views
Share
bullish•S&P 500 INDEX
•12 Dec 2019 21:11

U. S. Equity Strategy: Small-Caps Closing the Gap

Major averages in the US (S&P 500, Dow, Russell 2000) and Europe (STOXX 600 & 50) each had throwbacks to their prior breakout levels last...

Logo
518 Views
Share
bearish•Kao Corp
•28 Jun 2019 01:32

Merries Baby Diaper Business: Struggles to Continue Despite Company Remarks a Quick Turnaround

Kao is a well-known Japanese conglomerate involved in various business activities ranging from FMCG products to chemicals. The company operates in...

Logo
649 Views
Share
bearish•MabPharm
•20 May 2019 15:09

Mabpharm IPO Preview: Mixed Prospects of Phase 3 Drug Candidates

MabPharm (2181 HK) is a pre-revenue biopharmaceutical company in China with a focus on drugs and biosimilars for cancers and autoimmune diseases....

Logo
686 Views
Share
•28 Mar 2019 08:56

Climate Action - School Strikes Hit a Spot, Carbon Emitters Face Heat. Investors Take Note

On Friday, March 15th, an estimated 1.6 million students in over 120 countries (source: Time magazine) walked out of classrooms and took to streets...

Logo
797 Views
Share
x